featured
Duration of Fracture Prevention After Zoledronate Treatment in Women With Osteopenia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Duration of fracture prevention after zoledronate treatment in women with osteopenia: observational follow-up of a 6-year randomised controlled trial to 10 years
Lancet Diabetes Endocrinol 2024 Apr 01;12(4)247-256, IR Reid, AM Horne, B Mihov, U Bava, A Stewart, GD GambleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.